Research to tackle heart conditions, cancer, mental health and vaccines are among 10 successful Flinders University-led projects to be awarded funding in the latest round of ³Ô¹ÏÍøÕ¾ Health and Medical Research grants.
Collectively, the 10 projects will share in $8,096,155 from the NHRMC’s Ideas Grant scheme, with the projects receiving funding for up to five years, commencing in 2022.
Deputy Vice-Chancellor (Research) Professor Robert Saint congratulated the researchers, highlighting the increase in the number of projects funded reflects Flinders’ growing research strengths.
“The growth in our research funding success and the outstanding success rate in this round, which is almost double the national average, is due to the efforts of our outstanding researchers who focus on research excellence and develop research proposals that will improve lives.
“These outcomes further cement a trend in our external grant funding, which has risen 66 percent in the last four years.
“The scope of the projects demonstrates that Flinders Health and Medical Research Institute is a hub for innovative health research, where fresh thinking from exceptional minds is being applied to society’s pressing health needs.”
and Associate Professor Erin Symonds are just some of the successful recipients of an NHRMC Ideas Grant.
The successfully awarded grants are:
- – Using renewal theory to develop personalised classification and treatment for atrial fibrillation – $1,166,529.20
- – Using population-based data to improve maternal asthma management and offspring health and development – $979,886.40
- – Vaccine nonspecific effects of live and non-live vaccines: understanding the mechanisms and potential consequences – $883,314.00
- – Do patients with symptoms need a colonoscopy? A novel panel of non-invasive biomarkers to determine need for diagnostic investigation – $881,020.40
- – The contribution of the gut to bipolar disorder – $844,809.80
- – Development and mechanistic analysis of novel inhibitors of the dengue virus NS1 protein – $783,440.40
- – Development of a nociceptive measuring device capable of differentiating chronic pain states – $777,495.20
- – Harnessing a novel insulin receptor binding mechanism to therapeutic benefit – $727,642.00
- – Machine learning of randomised controlled trials: A major emerging opportunity to advance precision oncology – $560,598.00
- – Determining the role of Target of Rapamycin Complex 2 (TORC2) in cancer cell proliferation – $491,420.00
The Ideas Grant Scheme was introduced in 2019 and is designed to support outstanding medical research, providing greater opportunities for more breakthroughs, so that Australians of all ages have improved health.
